You just read:

Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.

News provided by

Synthetic Biologics, Inc.

Feb 22, 2013, 07:00 EST